Table 3.
Relative frequencies of nucleotide insertions/deletions detected
| Clinical stage (n/total) | Patient | Relative frequency (% of mutated haplotypes) | |
| 1951 (1 nt: T) | 2085 (1 nt: G) | ||
| CHB (8/16) | 1 | 8.36 (8.7) | |
| 2 | 17.12 (40) | ||
| 3 | 3.19 (5) | ||
| 4 | 0.37 (5.9) | ||
| 9 | 2.02 (8.82) | ||
| 10 | 1.34 (50) | ||
| 12 | 1.04 (10) | ||
| 13 | 2.79 (22.22) | ||
| HCC (2/17) | 28 | 0.78 (4) | |
| 33 | 2.42 (4.8) | ||
| LC (1/5) | 34 | 17.42 (19.2) | |
The table shows the relative frequency of insertions/deletions, together with the percentage (%) of mutated haplotypes per patient. Only patients carrying these mutations were included in the table. CHB: Chronic hepatitis B infection without liver damage; HCC: Hepatocellular carcinoma; LC: Liver cirrhosis; T: Thymine; G: Guanine; nt: Nucleotide.